Your search history is turned on.
Date: February 8, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, North West Territories, Ontario, Quebec, Saskatchewan, Yukon
Microsoft Word - PRHM_DM-#1344805-v1-MCR_-_Closing_of_Office_at_100_Sussex _3_.DOC PHARMAGAP INC. 1000 Innovation Drive, Suite 400 Ottawa, Ontario K2K 3E7. February 4, 2013 MATERIAL CHANGE REPORT Item 1. Name and Address of Company The name of the reporting issuer is PharmaGap Inc. (the Issuer" or PharmaGap). Its registered office is located at ...
Microsoft Word - PRHM_DM-#1345947-v1-MCR_-_Kavanagh_Resignation.DOC PHARMAGAP INC. 1400 340 Albert Street Ottawa, Ontario K1R 0A5 February 6, 2013 MATERIAL CHANGE REPORT Item 1. Name and Address of Company The name of the reporting issuer is PharmaGap Inc. (the Issuer" or PharmaGap). Its registered office is located at 1400 340 Albert Street...
Date: February 6, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, North West Territories, Ontario, Quebec, Saskatchewan, Yukon
Microsoft Word - PRHM_DM-#1345469-v3-Tier_2_Notice_News_Release.docx PharmaGap Receives Notice of Pending Transfer to NEX Exchange Ottawa, Ontario/February 6, 2013 PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) (PharmaGap or the Company) today received notice from the TSV Venture Exchange (the Exchange) advising the Company of deficiencies in the exchanges Tier 2...
Date: February 4, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, North West Territories, Ontario, Quebec, Saskatchewan, Yukon
Microsoft Word - PRHM_DM-#1343430-v2-Close_Up_News_Release.DOC PharmaGap Provides Update on Status Ottawa, Ontario Feb 4, 2013 PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) (PharmaGap or the Company) today was informed by Clinical Value Corporation (CVC) that it has not, to date, been successful in efforts arranging funding required to complete the license of the...
Date: November 29, 2012 Jurisdictions: Alberta, British Columbia, Manitoba, North West Territories, Ontario, Quebec, Saskatchewan, Yukon
YEAR END REPORT PHARMAGAP INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2012 (in Canadian dollars, unless otherwise indicated) - 1 - Date of Report November 29, 2012 This Management Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to assist in ...
Consolidated Financial Statements of Condensed Financial Statements of PHARMAGAP INC. For the three and nine months ended September 30, 2012 and 2011 (unaudited) Notice to Reader The accompanying unaudited interim condensed ...
Date: October 11, 2012 Jurisdictions: Alberta, British Columbia, Manitoba, North West Territories, Ontario, Quebec, Saskatchewan, Yukon
Microsoft Word - PRHM_DM-#1298525-v1-MCR_-_Cost_Reduction_Program.DOC PHARMAGAP INC. 100 Sussex Drive Ottawa, Ontario K1A 0R6. October 4, 2012 MATERIAL CHANGE REPORT Item 1. Name and Address of Company The name of the reporting issuer is PharmaGap Inc. (the Issuer" or PharmaGap). Its head office is located at 100 Sussex Drive, Ottawa, Ontario, K...
Date: October 4, 2012 Jurisdictions: Alberta, British Columbia, Manitoba, North West Territories, Ontario, Quebec, Saskatchewan, Yukon
Microsoft Word - PRHM_DM-#1298530-v1-Cost_Reduction_Program_News_Release.DOC PharmaGap Announces Cost Reduction Program To Preserve Asset Value OTTAWA, Oct. 2, 2012 /CNW/ - PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) ("PharmaGap" or "the Company") today announced that it is suspending all operations pending completion of the previously announced licensing transaction ...